Absence of mutations in the p53 tumor suppressor gene in woodchuck hepatocellular carcinomas associated with hepadnavirus infection and intake of aflatoxin B1

Carcinogenesis

Volumn 17, Issue 12, 1996, Pages 2689-2694

  Rivkina, Marianne ^a   Cote, Paul J ^b   Robinson, William S ^a   Tennant, Bud C ^c   Marion, Patricia L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA VIRUS; EXON; GENE MUTATION; LIVER CELL CARCINOMA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SPLICEOSOME; SQUIRREL; TUMOR SUPPRESSOR GENE; VIRUS INFECTION; WOODCHUCK;

AFLATOXIN B1; ANIMALS; CARCINOGENS; CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; EXONS; GENES, P53; HEPATITIS B; HEPATITIS B VIRUS, WOODCHUCK; LIVER NEOPLASMS; MARMOTA; MUTATION;

EID: 0030449113     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.12.2689     Document Type: Article

References (58)

1. Sherker,A.H. and Marion,P.L. (1991) Hepadnaviruses and hepatocellular carcinoma. Annu. Rev. Microbiol., 45, 475-508.
2. Robinson,W.S. (1994) Molecular events in the pathogenesis of hepadna-virus-associated hepatocellular carcinoma. Annu. Rev. Med., 45, 297-323.
3. Buendia,M.-A. (1992) Hepatitis B viruses and hepatocellular carcinoma. Adv. Cancer Res., 59, 167-226.
4. Marion,P.L., Popper,H., Azcarraga,R.R., Steevens,C., Van Davelaar,M.J. and Robinson,W.S. (1987) Ground squirrel hepatitis virus and hepatocellular carcinoma. In Robinson,W.S., Koike,K., Will,H. (eds), Hepadna Viruses, UCLA Symposia on Molecular and Cellular Biology, New Series, vol. 70, Alan R. Liss, Inc., New York, pp.337-348.
5. Paronetto,F. and Tennant,B.C. (1990) Woodchuck hepatitis virus infection: a model of human hepatic diseases and hepatocellular carcinoma. In Popper,H. and Schaffer,F. (eds), Progress in Liver Diseases, vol. IX, W.B. Saunders Company, Harcourt Brace Jovanovich, Inc., Philadelphia, pp. 463-483.
6. Shafritz,D.A., Shouval,D., Sherman,H., Hadziyannis,S. and Kew,M.C. (1981) Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. N. Engl. J. Med., 305, 1067-1073.
7. Rogler,C.E. and Summers,J. (1984) Cloning and structural analysis of integrated woodchuck hepatitis virus sequences from a chronically infected liver. J. Virol., 50, 832-837.
8. Boender,P.J., Schalm,S.W. and Heitjtink,R.A. (1985) Detection of integration during active replication of hepatitis B virus in the liver. J. Med. Virol., 16, 47-54.
9. Hsu,T.Y., Möröy,T., Etiemble,J., Louise,A., Trépo,C., Tiollais,P. and Buendia,M.-A. (1988) Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma. Cell, 55, 627-635.
10. Fourel,G., Trépo,C., Bougueleret,L., Henglein,B., Ponzetto,A., Tiollais,P. and Buendia,M.-A. (1990) Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumors. Nature (Lond.), 347, 294-298.
11. Wei,Y., Fourel,G., Ponzetto,A., Silvestro,M., Tiollais,P. and Buendia, M.-A. (1992) Hepadnavirus integration: Mechanisms of activation of the N-myc2 retrotransposon in woodchuck liver tumors. J. Virol., 66, 5265-5276.
12. Transy,C., Renard,C.A. and Buendia,M.-A. (1994) Analysis of integrated ground squirrel hepatitis virus and flanking host DNA in two hepatocellular carcinomas. J. Virol., 68, 5291-5295.
13. Transy,C, Fourel,G., Robinson,W.S., Tiollais,P., Marion,P.L. and Buendia,M.-A. (1992) Frequent amplification of c-myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirus. Proc. Natl Acad. Sci. USA, 89, 3874-3878.
14. Rogler,C. (1991) Cellular and molecular mechanisms of hepato-carcinogenesis associated with hepadnavirus infection. Curr. Topics Microbiol. Immunol., 168, 103-140.
15. Tokino,T. and Matsubara,K. (1991) Chromosomal sites for hepatitis B virus integration in human hepatocellular carcinoma. J. Virol., 65, 6761-6764.
16. Zhou,Y.-Z., Slagle,B.L., Donehower,L.A., van Tuinen,P., Ledbetter,D.H. and Butel,J.S. (1988) Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma. J. Virol., 62, 4224-4231.
17. Wang,H.P. and Rogler,C.E. (1988) Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet. Cell. Genet., 48, 72-78.
18. Hollingsworth,R.E. and Lee,W.-H. (1991) Tumor suppressor genes: new prospects for cancer research. J. Natl Cancer Inst., 83, 91-96.
19. Slagle,B.L., Zhou,Y.-Z. and Butel,J.S. (1991) Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. Cancer Res., 51, 49-54.
20. Fujimoto,Y., Hampton,L.L., Wirth,P.J., Wang,N.J., Xie,J.P. and Thorgeirsson,S.S. (1994) Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res., 54, 281-285.
21. Murakami,Y., Hayashi,K., Hirihashi,S. and Sekiya,T. (1991) Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res., 51, 5520-5525.
22. Caamano,J., Ruggeri,B.A. and Klein-Szanto,A.J.P. (1992) A catalog of p53 alterations in selected human and laboratory animal neoplasms. Prog. Clin. Biol. Res., 376, 331-355.
23. Chang,F., Syrjanen,S., Kurvinen,K. and Syrjanen,K. (1993) The p53 tumor suppressor gene as a common cellular target in human carcinogenesis. Amer. J. Gastroent., 88, 174-186.
24. Greenblatt,M.S., Bennett,W.P., Hollstein,M. and Harris,C.C. (1994) Mutations in the p53 tumor supressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
25. Hsu,I.C., Metcalf,R.A., Sun,T., Welsh,J.A., Wang,N.J. and Harris,C.C. (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature (Lond.), 350, 427-428.
26. Bressac,B., Kew,M., Wands,J. and Ozturk,M. (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature (Lond.), 350, 429-431.
27. Scorzone,K.A., Zhou,Y.-Z., Butel,J.S. and Slagle,B.L. (1992) p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res., 52, 1635-1638.
28. Unsal,H., Yakicier,C., Marçais,C., Kew,M., Volkman,M., Zentgraf,H., Isselbacher,K.J. and Ozturk,M. (1994) Genetic heterogeneity of hepatocellular carcinoma. Proc. Natl Acad. Sci. USA, 91, 822-826.
29. Harris,C. and Sun,T.-T. (1984) Multifactoral etiology of human liver cancer. Carcinogenesis, 6, 697-701.
30. Wogan,G.N. (1992) Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res., 52(Suppl. 7), 2114s-2118s.
31. Aguilar,F., Harris,C.C., Sun,T., Hollstein,M. and Cerutti,P. (1994) Geographic variation of p53 mutational profile in nonmalignant human liver. Science, 264, 1317-1319.
32. Kress,S., Jahn,U.-R., Buchman,A., Bannasch,P. and Schwartz,M. (1992) p53 mutations in human hepatocellular carcinomas from Germany. Cancer Res., 52, 3220-3223.
33. Sheu,J.-C. Huang,G.-T., Lee,P.-H. et al. (1992) Mutation of p53 gene in hepatocellular carcinoma in Taiwan. Cancer Res., 52, 6098-6100.
34. Oda,T., Tsuda,H., Scarpa,A., Sakamoto,M. and Hirohashi,S. (1992) p53 Gene mutation spectrum in hepatocellular carcinoma. Cancer Res., 52, 6358-6364.
35. Rivkina,M.B., Cullen,J.M., Robinson,W.S. and Marion,P.L. (1994) State of the p53 gene in hepatocellular carcinomas of ground squirrels and woodchucks with past and ongoing infection with hepadnaviruses. Cancer Res., 54, 5430-5437.
36. Cote,P., Roneker,C., Cass,K., Schödel,F., Peterson,D., Tennant,B., de Noronha,F. and Gerin,J. (1993) New enzyme immunoassays for the serologic detection of woodchuck hepatitis virus infection. Viral Immunol., 6, 161-169.
37. Seeger,C., Ganem,D. and Varmus,H.E. (1984) Nucleotide sequence of an infectious molecularly cloned genome of ground squirrel hepatitis virus. J. Virol., 51, 367-375.
38. Cohen,J.I., Miller,R.H., Rosenblum,B., Denniston,K., Gerin,J.L. and Purcell,R.H. (1988) Sequence comparison of woodchuck hepatitis virus replicative forms shows conservation of the genome. Virology, 162, 12-20.
39. Duflot,A., Hollstein,M., Mehrotra,R., Trepo,C., Montesano,R. and Cova, L. (1994) Absence of p53 mutation at codon 249 in duck hepatocellular carcinomas from the high incidence area of Qidong (China). Carcinogenesis, 15, 1353-1357.
40. 1-induced rat hepatic hyperplastic nodules do not exhibit a site-specific mutation within the p53 gene. Cancer Res., 53, 9-11.
41. Zakut-Houri,R., Bienz-Tadmor,B., Givol,D. and Oren,M. (1985) Human p53 cellular antigen: cDNA sequence and expression in COS cells. EMBO J., 4, 1251-1255.
42. Rigaudy,P. and Eckhart,W. (1989) Nucleotide sequence of a cDNA encoding the monkey cellular phosphoprotein p53. Nucl. Acids Res., 17, 8375.
43. Soussi,T., de Fromental,C., Breugnot,C. and May,P. (1988) Nucleotide sequence of a cDNA encoding the rat p53 nuclear oncoprotein. Nucl. Acids Res., 16, 11384.
44. Bienz,B., Zakut-Houri,R., Givol,D. and Oren,M. (1984) Analysis of the gene coding for the murine cellular tumour antigen p53. EMBO J., 3, 2179-2183.
45. 1-DNA interactions. Proc. Natl Acad. Sci. USA, 80, 6-10.
46. Seeberg,E. and Fuchs,R. (1990) Acetylaminofluorene bound to different guanines of the sequence -GGCGCC- is excised with different efficiencies by the UvrABC excision nuclease in a pattern not correlated to the potency of mutation induction. Proc. Natl Acad. Sci. USA, 87, 191-194.
47. 1 in nonhuman primates. Cancer Res., 52, 1044-1046.
48. 1 in the monkey, rat and mouse. Toxicol. Appl. Pharmacol., 55, 115-125.
49. 1 on the livers of rats and duck hepatitis B virus-infected and noninfected ducks. Hepatology, 18, 188-197.
50. 1. Proc. Natl Acad. Sci. USA, 92, 2384-2387.
51. Cross,J.C., Wen,P. and Rutter,W.J. (1993) Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. Proc. Natl Acad. Sci. USA, 90, 8078-8082.
52. Wang,X.W., Forrester,K., Yeh,H., Feitelson,M.A., Gu,J.-R. and Harris,C.C. (1994) Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and associated with transcription factor ERCC3. Proc. Natl Acad. Sci. USA, 91, 2230-2234.
53. Truant,R., Antunovic,J., Greenblatt,J., Prives,C. and Cromlish,J.A. (1995) Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. J. Virol., 69, 1851-1859.
54. Wang,X.W., Gibson,M.K., Vermeulen,W., Yeh,H., Forrester,K., Stürzbecher,H.-W., Hoeijmakers,J.H.J. and Harris,C. (1995) Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res., 55, 6012-6016.
55. Henkler,F., Waseem,N., Golding,M.H.C., Alison,M.R. and Koshy,R. (1995) Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus-related human hepatocellular carcinoma. Cancer Res., 55, 6084-6091.
56. Puisieux,A., Ji,J., Guillot,C., Legros,Y., Soussi,T., Isselbacher,K. and Ozturk,M. (1995) p53-Mediated cellular response to DNA damage in cells with replicative hepatitis B virus. Proc. Natl Acad. Sci. USA, 92, 1342-1346.
57. Fourel,G., Couturier,J., Wei,Y., Apiou,F., Tiollais,P. and Buendia,M.-A. (1994) Evidence for long range oncogene activation by hepadnavirus insertion. EMBO J., 13, 2526-2534.
58. Yang,D., Alt,E. and Rogler,C.E. (1993) Coordinate expression of N-myc 2 and insulin-like growth factor II in precancerous altered hepatic foci in woodchuck hepatitis virus carriers. Cancer Res., 53, 2020-2027.